Declaration of Competing Interest statements were not included in the published version of the following articles that appeared in previous issues of Diabetes & Metabolic Syndrome: Clinical Research & Reviews.
The appropriate Declaration/Competing Interest statements, provided by the Authors, are included below.
-
1.
“Doctors and healthcare workers at frontline of COVID 19 epidemic: Admiration, a pat on the back, and need for extreme caution” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (3): 255–256] https://doi.org/10.1016/j.dsx.2020.03.006
Declaration of competing interest: The Authors have no interests to declare.
-
2.
“Escalating cost of oral and injectable antihyperglycemic drugs; are newer medications worth their price? A perspective from India and other developing countries” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (2): 167–169] https://doi.org/10.1016/j.dsx.2020.01.012
Declaration of competing interest: The Authors have no interests to declare.
-
3.
“Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infection with reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc)” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (3): 251–254] https://doi.org/10.1016/j.dsx.2020.03.012
Declaration of competing interest: The Authors have no interests to declare.
-
4.
“COVID-19 pandemic and challenges for socio-economic issues, healthcare and National Health Programs in India” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (5): 757–759] https://doi.org/10.1016/j.dsx.2020.05.041
Declaration of competing interest: The Authors have no interests to declare.
-
5.
“Clinical considerations for patients with diabetes in times of COVID-19 epidemic” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (3): 211–212] https://doi.org/10.1016/j.dsx.2020.03.002
Declaration of competing interest: The Authors have no interests to declare.
-
6.
“Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (4): 273–276] https://doi.org/10.1016/j.dsx.2020.04.001
Declaration of competing interest: The Authors have no interests to declare.
-
7.
“Heterogeneity of diabetes - An Indian perspective” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2018; 13 (5): 3065–3067] https://doi.org/10.1016/j.dsx.2018.07.001
Declaration of competing interest: The Authors have no interests to declare.